Hormonal regulation of Acetyl-CoA carboxylase isoenzyme gene transcription

Endocrine Journal

Volumn 57, Issue 4, 2010, Pages 317-324

  Zhao, Li Feng ^a   Iwasaki, Yasumasa ^a   Zhe, Wang ^a   Nishiyama, Mitsuru ^a   Taguchi, Takafumi ^a   Tsugita, Makoto ^a   Kambayashi, Machiko ^a   Hashimoto, Kozo ^a   Terada, Yoshio ^a  

^a KOCHI UNIVERSITY   (Japan)

Author keywords

Acetyl CoA carboxylase; Fatty acid; Glucocorticoid; Insulin; Obesity

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; GLUCOCORTICOID; INSULIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C;

ARTICLE; CONTROLLED STUDY; FATTY LIVER; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HORMONAL REGULATION; HUMAN; HUMAN CELL; LIPOLYSIS; OBESITY; PATHOGENESIS; PROMOTER REGION; TRANSCRIPTION REGULATION;

ACETYL-COA CARBOXYLASE; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; GENE EXPRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOCORTICOIDS; HEP G2 CELLS; HEPATOCYTES; HUMANS; INSULIN; ISOENZYMES; KINETICS; ORPHAN NUCLEAR RECEPTORS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 77953631114     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K09E-298     Document Type: Article

References (37)

1. Wakil SJ, Abu-Elheiga LA (2009) Fatty acid metabolism: target for metabolic syndrome. J Lipid Res 50 (Suppl): S138-S143.
2. López-Casillas F, Ponce-Castañeda MV, Kim KH. Mao J, DeMayo FJ (1992) Acetyl-coenzyme A carboxylase mRNA metabolism in the rat liver. Metabolism 41: 201-207.
3. Katsurada A, Iritani N, Fukuda H, Matsumura Y, Nishimoto N, Noguchi T, Tanaka T (1990) Effects of nutrients and hormones on transcriptional and posttranscriptional regulation of acetyl-CoA carboxylase in rat liver. Eur J Biochem 190: 435-441.
4. Salati LM, Clarke SD (1986) Fatty acid inhibition of hormonal induction of acetyl-coenzyme A carboxylase in hepatocyte monolayers. Arch Biochem Biophys 246: 82-89.
5. Abu-Elheiga L, Jayakumar A, Baldini A, Chirala SS, Wakil SJ (1995) Human acetyl-CoA carboxylase: characterization, molecular cloning, and evidence for two isoforms. Proc Natl Acad Sci USA 92: 4011-4015.
6. Abu-Elheiga L, Almarza-Ortega DB, Baldini A, Wakil SJ (1997) Human acetyl-CoA carboxylase 2. Molecular cloning, characterization, chromosomal mapping, and evidence for two isoforms. J Biol Chem 272: 10669-10677.
7. Abu-Elheiga L, Brinkley WR, Zhong L, Chirala SS, Woldegiorgis G, Wakil SJ (2000) The subcellular localization of acetyl-CoA carboxylase 2. Proc Natl Acad Sci USA 97: 1444-1449.
8. Mao J, DeMayo FJ, Li H, Abu-Elheiga L, Gu Z, Shaikenov TE, Kordari P, Chirala SS, Heird WC, Wakil SJ (2006) Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. Proc Natl Acad Sci USA 103: 8552-8557.
9. Kim KW, Yamane H (2006) Expression, purification, and characterization of human acetyl-CoA carboxylase 2. Protein Expr Purif 53: 16-23.
10. Choi CS, Savage DB, Abu-Elheiga L, Liu ZX, Kim S, Kulkarni A, Distefano A, Hwang YJ, Reznick RM, Codella R, Zhang D, Cline GW, Wakil SJ, Shulman GI (2007) Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity. Proc Natl Acad Sci USA 104: 16480-16485.
11. Mao J, Chirala SS, Wakil SJ (2003) Human acetyl-CoA carboxylase 1 gene: presence of three promoters and heterogeneity at the 5'-untranslated mRNA region. Proc Natl Acad Sci USA 100: 7515-7520.
12. Oh SY, Lee MY, Kim JM, Yoon S, Shin S, Park YN, Ahn YH, Kim KS (2005) Alternative usages of multiple promoters of the acetyl-CoA carboxylase beta gene are related to differential transcriptional regulation in human and rodent tissues. J Biol Chem 280: 5909-5916.
13. Shimano H (2001) Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 40: 439-452.
14. Grefhorst A, Elzinga BM, Voshol PJ, Plösch T, Kok T, Bloks VW, van der Sluijs FH, Havekes LM, Romijn JA, Verkade HJ, Kuipers F (2002) Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceriderich very low density lipoprotein particles. J Biol Chem 277: 34182-34190.
15. Oh SY, Park SK (2003) Acetyl-CoA carboxylase beta gene is regulated by sterol regulatory element-binding protein-1 in liver. J Biol Chem 278: 28410-28407.
16. Denechaud PD, Bossard P, Lobaccaro JM, Millatt L, Staels B, Girard J, Postic C (2008) ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver. J Clin Invest 118: 956-964.
17. Aoki Y, Iwasaki Y, Katahira M, Oiso Y, Saito H (1997) Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. I: Effects of the common secretagogues. Endocrinology 138: 1923-1929.
18. Katz NR, Ick M (1981) Induction of acetyl-CoA carboxylase in primary rat hepatocyte cultures by glucose and insulin. Biochem Biophys Res Commun 100: 703-709.
19. Choi DH, Choi JH, Whang SK, Kim YS (1989) Regulation of acetyl CoA carboxylase mRNA in rat liver by high carbohydrate diet and insulin. Yonsei Med J 30: 235-245.
20. Fukuda H, Katsurada A, Iritani N (1992) Nutritional and hormonal regulation of mRNA levels of lipogenic enzymes in primary cultures of rat hepatocytes. J Biochem 111: 25-30.
21. Diamant S, Shafrir E (1975) Modulation of the activity of insulin-dependent enzymes of lipogenesis by glucocorticoids. Eur J Biochem 53: 541-546.
22. Yanovski JA, Cutler GB Jr (1994) Glucocorticoid action and the clinical features of Cushing's syndrome. Endocrinol Metab Clin North Am 23: 487-509.
23. Rockall AG, Sohaib SA, Evans D, Kaltsas G, Isidori AM, Monson JP, Besser GM, Grossman AB, Reznek RH (2003) Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography. Eur J Endocrinol 149: 543-548.
24. Mounier C, Posner BI (2006) Transcriptional regulation by insulin: from the receptor to the gene. Can J Physiol Pharmacol 84: 713-724.
25. Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, Goldstein JL, Brown MS (1993) SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein recaptor gene. Cell 75: 187-197.
26. Kim JB, Spotts GD, Halvorsen YD, Shih HM, Ellenberger T, Towle HC, Spiegelman BM (1995) Dual DNA binding specificity of ADD1/SREBP1 controlled by a single amino acid in the basic helix-loop-helix domain. Mol Cell Biol 15: 2582-2588.
27. Wójcicka G, Jamroz-Wiśniewska A, Horoszewicz K, Bełtowski J (2007) Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism. Postepy Hig Med Dosw 61: 736-759.
28. Mitro N, Mak PA, Vargas L, Godio C, Hampton E, Molteni V, Kreusch A, Saez E (2007) The nuclear receptor LXR is a glucose sensor. Nature 445: 219-223.
29. Ishii S, Iizuka, Miller BC, Uyeda K (2004) Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc Natl Acad Sci USA 101: 15597-15602.
30. Postic C, Dentin R (2007) ChREBP, a transcriptional regulator of glucose and lipid metabolism. Annu Rev Nutr 27: 179-192.
31. Da Silva Xavier G, Rutter GA, Diraison F, Andreolas C, Leclerc I (2006) ChREBP binding to fatty acid synthase and L-type pyruvate kinase genes is stimulated by glucose in pancreatic beta-cells. J Lipid Res 47: 2482-1491.
32. Tsatsos NG, Towle HC (2006) Glucose activation of ChREBP in hepatocytes occurs via a two-step mechanism. Biochem Biophys Res Commun 340: 449-456.
33. Tobin KA, Ulven SM, Schuster GU, Steineger HH, Andresen SM, Gustafsson JA, Nebb HI (2002) Liver X receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis. J Biol Chem 277: 10691-10697.
34. Iwasaki Y, Takayasu S, Nishiyama M, Tsugita M, Taguchi T, Asai M, Yoshida M, Kambayashi M, Hashimoto K (2008) Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11β-hydroxysteroid dehydrogenase type 1) gene. Mol Cell Endocrinol 285: 10-18.
35. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP (2009) The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab 94: 2692-2701.
36. Harwood HJ Jr (2005) Treating the metabolic syndrome: acetyl-CoA carboxylase inhibition. Expert Opin Ther Targets 9: 267-281.
37. Corbett JW (2009) Review of recent acetyl-CoA carboxylase inhibitor patents: mid-2007-2008. Expert Opin Ther Pat 19: 943-956.